Efficacy and safety of two regimens of low molecular weight heparin fragment (Fragmin) in preventing postoperative venous thrombolism

Haemostasis
V V KakkarC E Peers

Abstract

The efficacy and safety of 2 regimens of Fragmin in preventing postoperative venous thromboembolism was compared on 206 consecutive patients, aged 40 years or more, undergoing major abdominal surgery. Ninety-four patients received a single daily injection of 2,500 U of Fragmin for at least 6 postoperative days (group I), while 112 received 5000 U per day in 2 injections of 2,500 U each (group II). In group I 7.4% of patients and in group II 2.6% of patients developed postoperative deep venous thrombosis (DVT); the difference was not statistically significant (p greater than 0.05). There was no significant difference between the 2 groups in terms of numbers of patients having excessive postoperative blood loss, requiring prophylaxis to be discontinued, or measured postoperative drainage. None of the patients in group I, and 2 out of 112 in group II developed wound haematoma. These findings suggest that a single daily injection of 2,500 U of Fragmin may provide an effective prophylaxis against postoperative venous thromboembolism.

Citations

Sep 1, 1990·World Journal of Surgery·V V Kakkar, M D Stringer
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·G G Nenci
Apr 14, 2012·Bioorganicheskaia khimiia·V B KrylovN E Nifant'ev
Aug 22, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Mohammad R IrhimehRay M Lowenthal
Feb 1, 1988·American Journal of Surgery·M O Perry
Jan 11, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Claudia A SnijderJohannes J Duvekot
Jul 1, 1997·American Journal of Surgery·A T CohenM S Mohamed
Nov 1, 1988·The British Journal of Surgery·B I ErikssonB Risberg
Nov 1, 2001·The Cochrane Database of Systematic Reviews·P Wille-JørgensenL Borly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P M MannucciN Cascinelli
American Heart Journal
S Wessler, S N Gitel
© 2021 Meta ULC. All rights reserved